{"id":"https://openalex.org/W2017046782","doi":"https://doi.org/10.1016/j.bmcl.2010.01.138","title":"Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists","display_name":"Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists","publication_year":2010,"publication_date":"2010-02-09","ids":{"openalex":"https://openalex.org/W2017046782","doi":"https://doi.org/10.1016/j.bmcl.2010.01.138","mag":"2017046782","pmid":"https://pubmed.ncbi.nlm.nih.gov/20207138"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2010.01.138","doi":"https://doi.org/10.1016/j.bmcl.2010.01.138","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2010.01.138","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070581361","display_name":"Paul J. Coleman","orcid":"https://orcid.org/0000-0003-4266-3227","observed_orcids":["https://orcid.org/0000-0003-4266-3227"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul J. Coleman","raw_affiliation_strings":["Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA. paul_coleman@merck.com","Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA. paul_coleman@merck.com","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058525540","display_name":"John D. Schreier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John D. Schreier","raw_affiliation_strings":["Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029909734","display_name":"Georgia B. McGaughey","orcid":"https://orcid.org/0000-0002-3586-965X","observed_orcids":["https://orcid.org/0000-0002-3586-965X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Georgia B. McGaughey","raw_affiliation_strings":["Department of Chemical Modeling and Informatics, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemical Modeling and Informatics, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074218389","display_name":"Michael J. Bogusky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Bogusky","raw_affiliation_strings":["Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067918981","display_name":"Christopher D. Cox","orcid":"https://orcid.org/0000-0001-9986-1561","observed_orcids":["https://orcid.org/0000-0001-9986-1561"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher D. Cox","raw_affiliation_strings":["Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031350782","display_name":"George D. Hartman","orcid":"https://orcid.org/0000-0002-8016-8369","observed_orcids":["https://orcid.org/0000-0002-8016-8369"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George D. Hartman","raw_affiliation_strings":["Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103501730","display_name":"Richard G. Ball","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard G. Ball","raw_affiliation_strings":["Department of Pharmaceutical Research and Development, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Research and Development, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054967559","display_name":"C. Meacham Harrell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Meacham Harrell","raw_affiliation_strings":["Department of Depression and Circadian Disorders, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Depression and Circadian Disorders, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046673026","display_name":"Duane R. Reiss","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Duane R. Reiss","raw_affiliation_strings":["Department of Depression and Circadian Disorders, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Depression and Circadian Disorders, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017950194","display_name":"Thomayant Prueksaritanont","orcid":"https://orcid.org/0000-0001-6810-9692","observed_orcids":["https://orcid.org/0000-0001-6810-9692"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomayant Prueksaritanont","raw_affiliation_strings":["Department of Drug Metabolism, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012881642","display_name":"Christopher J. Winrow","orcid":"https://orcid.org/0000-0001-8248-4157","observed_orcids":["https://orcid.org/0000-0001-8248-4157"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher J. Winrow","raw_affiliation_strings":["Department of Depression and Circadian Disorders, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Depression and Circadian Disorders, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087832273","display_name":"John J. Renger","orcid":"https://orcid.org/0000-0001-8418-8642","observed_orcids":["https://orcid.org/0000-0001-8418-8642"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John J. Renger","raw_affiliation_strings":["Department of Depression and Circadian Disorders, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Depression and Circadian Disorders, Merck Research Laboratories, PO Box 4, Sumneytown Pike, West Point, PA 19486, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":1.5621,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":{"value":0.81174675,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"20","issue":"7","first_page":"2311","last_page":"2315"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.6669999957084656,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.6669999957084656,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.13590000569820404,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10985","display_name":"Sleep and Wakefulness Research","score":0.03929999843239784,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/orexin-receptor-antagonists","display_name":"orexin receptor antagonists","score":0.9760000109672546},{"id":"https://openalex.org/keywords/1-4-diazepane","display_name":"1,4-diazepane","score":0.9490000009536743},{"id":"https://openalex.org/keywords/conformationally-constrained-analogs","display_name":"conformationally constrained analogs","score":0.8769999742507935},{"id":"https://openalex.org/keywords/orexin","display_name":"orexin","score":0.6430000066757202},{"id":"https://openalex.org/keywords/insomnia","display_name":"insomnia","score":0.7200000286102295},{"id":"https://openalex.org/keywords/sleep-disturbance","display_name":"sleep disorders","score":0.9879999756813049},{"id":"https://openalex.org/keywords/wakefulness","display_name":"wakefulness","score":0.47699999809265137},{"id":"https://openalex.org/keywords/small-molecule-drug-design","display_name":"small-molecule drug design","score":0.5590000152587891}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8637492656707764},{"id":"https://openalex.org/C2779680196","wikidata":"https://www.wikidata.org/wiki/Q410857","display_name":"Orexin","level":4,"score":0.8461118936538696},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.573270857334137},{"id":"https://openalex.org/C2779320081","wikidata":"https://www.wikidata.org/wiki/Q246710","display_name":"Wakefulness","level":3,"score":0.5489044189453125},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.53934645652771},{"id":"https://openalex.org/C2779605129","wikidata":"https://www.wikidata.org/wiki/Q24785218","display_name":"Orexin receptor","level":5,"score":0.48954257369041443},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.4297317862510681},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3804181218147278},{"id":"https://openalex.org/C118303440","wikidata":"https://www.wikidata.org/wiki/Q419968","display_name":"Neuropeptide","level":3,"score":0.37843847274780273},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19065633416175842},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.1489727795124054},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.12009790539741516},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10105675458908081},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.06045237183570862},{"id":"https://openalex.org/C522805319","wikidata":"https://www.wikidata.org/wiki/Q179965","display_name":"Electroencephalography","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012893","descriptor_name":"Sleep Wake Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018013","descriptor_name":"Receptors, Neuropeptide","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018013","descriptor_name":"Receptors, Neuropeptide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043562","descriptor_name":"Receptors, G-Protein-Coupled","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D043562","descriptor_name":"Receptors, G-Protein-Coupled","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064446","descriptor_name":"Orexin Receptors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2010.01.138","doi":"https://doi.org/10.1016/j.bmcl.2010.01.138","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2010.01.138","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:20207138","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20207138","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1966757180","https://openalex.org/W1978258287","https://openalex.org/W1978705163","https://openalex.org/W1992009633","https://openalex.org/W1994751724","https://openalex.org/W1998115942","https://openalex.org/W1999083454","https://openalex.org/W2020469752","https://openalex.org/W2027740042","https://openalex.org/W2033473705","https://openalex.org/W2056981505","https://openalex.org/W2105649494","https://openalex.org/W2152211310","https://openalex.org/W2160274156","https://openalex.org/W2166416819"],"related_works":["https://openalex.org/W1972108149","https://openalex.org/W2166416819","https://openalex.org/W1983052558","https://openalex.org/W2137616428","https://openalex.org/W2913775597","https://openalex.org/W2033581027","https://openalex.org/W2545333556","https://openalex.org/W2021283318","https://openalex.org/W2944107830","https://openalex.org/W2180588909"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}